Evidence map›Paper›PMID 36973669›Full record

ArticleBMC cancer2023

Increased incidence and improved survival in endometrial cancer in Sweden 1960-2014: a population-based registry survey.

Filip Herbst, Paul W Dickman, Louise Moberg, Thomas Högberg, Christer Borgfeldt

Full text read
In one paragraph

Article in BMC cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Filip HerbstDepartment of Obstetrics and Gynecology, Skåne University Hospital Lund, Lund University, Klinikgatan 12, 221 85, Lund, Sweden. filip.herbst@med.lu.se.
Paul W DickmanDepartment of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.
Louise MobergDepartment of Obstetrics and Gynecology, Skåne University Hospital Lund, Lund University, Klinikgatan 12, 221 85, Lund, Sweden.
Thomas HögbergDepartment of Cancer Epidemiology, Skåne University Hospital Lund, Lund University, Lund, Sweden.
Christer BorgfeldtDepartment of Obstetrics and Gynecology, Skåne University Hospital Lund, Lund University, Klinikgatan 12, 221 85, Lund, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAn investigation of trends of incidence and net survival (NS) for endometrial cancer in Sweden.

methodsMorphologically verified endometrial carcinoma diagnosed 1960 to 2014 were collected from the nation-wide Swedish Cancer Registry. Endometrial cancer patients were assessed with regards to time trends for incidence and 54,825 cases remained for survival analyses. Cases diagnosed 1995 to 2014 were categorized according to detailed morphology and from 2005 to 2014 FIGO stage was also categorized.

resultsThere was a trend of increasing incidence of endometrial carcinoma for women above 55 years of age. NS was improved at 5- and 10-year follow-up. The 5-year net survival in 2010-2014 was 86%. The most prominent improvement in NS was found in the elderly women above 75 years of age.

conclusionsThis study observed increased incidence of endometrial cancer in Sweden from 1960 to 2014. The progress in diagnostics and treatment, seem to have improved the net survival, especially in elderly women.

Indexed as

Endometrial NeoplasmsAgedFemaleHumansIncidenceRegistriesSwedenCancer registryEndometrial cancerEndometrial carcinomaFIGO stageHistopathologyIncidenceLong-term follow-upNet survivalPopulation-based

Identifiers

PMID36973669
PMCPMC10045609

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read216
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.